Health Worlds

academic jour Chinese Journal of Practical Pediat 2006 antibiotics in the application of hemolytic uremic syndrome in Progress
Antibiotics in the application of hemolytic uremic syndrome in ProgressYou can in the "My Services" in the you add a reference to the notification list, and configure access to notices.Hemolytic uremic syndrome (hemolytic uremic syndrome, HUS) is caused by a variety of causes micro-vascular disease, clinical manifestations of microvascular hemolysis, thrombocytopenia and acute renal failure. Of: Fan Xi Yao Yong Chung Ji-yun Yang Peking University, the first a pediatric hospital, Beijing, 100034 Title: Chinese Journal of Practical Pediatrics ISTKU English title: CHINESE JOURNAL OF PRACTICAL PEDIATRICS, the volume (of): 2006 21 (8) Key words: R72 Keywords: Machine Standard Classification: R44 R87 Machine Standard Key words: antibiotics, intravascular hemolytic uremic clinical manifestations of acute renal failure, thrombocytopenia microangiopathic etiology Fund Project: DOI: References (18) Bennish ML.Khan WA.Begum MLow risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh 2006 (03) Ikeda K. Ida O. Kimoto KEffect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157: H7 infecti999 (06) Shiomi M. Togawa M. Fujita KEffect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157: H7 1999 (02


) Higami S. Nishimoto K. Kawamura TRetrospective analysis of the relationship between HUS incidence and antibiotics among patients with Escherichia coli O157 enterocolitis in the Sakai outbreak 1998 (03) Isogai E. Isogai H. HayashiEffect of antibiotics, LVFX and FOM, on a mouse model with Escherichia coli O157 infection 2000 (01) Ohara T. Kojio S. Taneike IEffects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response 2002 (11) Basualdo W. Arbo ARandomized comparison of azithromycin versus cefixime for treatment of shigellosis in children 2003 (04) Kurioka T. Yunou Y. Harada HEfficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157: H7 in mice with protein- calorie malnutriti999 (08) Wong CS.Jelacic S. Habeeb RLThe risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157: H7 infections 2000 (26) Zimmerhackl LBE.coli, antibiotics, and the hemolytic-uremic syndrome 2000 ( 26) Yoh M. Honda TThe stimulating effect of fosfomycin, an antibiotic in common use in Japan, on the production / release of verotoxin-1 from enterohaemorrhagic Escherichia coli O157: H7 in vitro 1997 (01) Bitzan M.Muller-Wiefel DE. Schwarzkopf AThe role of antibiotics in the management of verotoxin-associated hemolytic anemia syndromes 1992 (05) Kohsaka T. Tagawa M. Suzuki TThe old and new problems of the antibiotics treatment in hemorrhagic enterocolitis and hemolytic uremic syndrome, according to Japanese epidemiological studies 1997 ( 03) Safdar N. Said A. Gangnon RERisk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157: H7 enteritis: a meta-analysis 2002 (08) Moriguchi N. Yagi K. Yamamoto TThe drug sensitivity of enterohemorragic Escherichia coli and antibiotics treatment for hemorrhagic enterocolitis-from an outbreak of enterocolitis in Sakai city 1997 (07) Ito T. Akino E. Hiramatsu KEvaluation of antibiotics used for enterohemorrhagic Escherichia coli O157 enteritis-effect of various antibiotics on extracellular release of verotoxin 1997 (02) Hiramatsu K. Murakami J. Kishi KTreatment with rokitamycin suppresses the lethality in a murine model of Escherichia coli O157: H7 infection 2003 (05) Zhang Yuwen. Meng group. Zhouchun Ju 35 years Prevalence of hemolytic uremic syndrome in children, death case analysis and treatment progress [periodical Thesis] - Clinical Pediatrics 2003 (09)
More . similar to the literature cited relevant literature Bowen (1) LI Wen-juan. Rong Mountain. Qiao Xi, hemolytic uremic syndrome Progress [Papers] - International Journal of Urology 2008 (4)
More .

Reported 1 case of FK506 during treatment of hemolytic uremic syndrome (HUS). A female patient with acute myeloid leukemia; in April 1989 when the first remission from her HLA identical sister as if he made a bone marrow transplant bone marrow (BMR). For the prevention of graft versus host disease (GVHD) given daily cyclosporin 3mg/kg. 3 months after BMT chronic GVHD, involving the skin, eye, buccal mucosa were moss-like changes, liver dysfunction and pulmonary obstructive ventilatory defect. In a variety of treatment options, the use of prednisone, methylprednisolone, azathioprine, and cyclosporine, but not cure GVHD. 23 months after BMT, hepatic dysfunction and increased pulmonary obstructive ventilatory defect. Peripheral blood count and normal renal function; hemoglobin 149g / L, platelets 321 10 ~ 9 / L,
DOI: cnki: ISSN :1001-8751 .0.7
Snapshot text:
Reported 1 case of FK506 during treatment of hemolytic uremic syndrome (HUS). A female patient with acute myeloid leukemia; in 198, on April first remission from her HLA identical sister as if he made a bone marrow transplant bone marrow (BMR). For the prevention of graft versus host disease (GVHD) given daily cyclosporine 3mg/kg. 3 months after BMT chronic GVHD, involving anti-skin, dry eye, buccal mucosa were moss-like changes, liver dysfunction and pulmonary obstructive ventilatory defect. In a variety of treatment options, the use of prednisone, methylprednisolone, sulfur wow cried Yin and cyclosporine, but not cure GVHD. 23 months after BMT, hepatic dysfunction and increased pulmonary obstructive ventilatory defect. Peripheral blood count and normal renal function; hemoglobin 1499 / L, platelets 321 x10 "/ L, serum creatinine drunk 1.om .


Friends Links:Automation Control Blog
Automation Products Order Numbers